🔗 Permalink

Inventor profile of:

Sebastian MEYER

City:

Eggenwil

Country:

Switzerland

Published Applications:

Last publication date:

2023-09-07

Top Assignees for applications by Sebastian MEYER

The entities that hold a legal rights for patent applications filed by inventor MEYER Sebastian:

NUMAB THERAPEUTICS AG 5 Wädenswil, Switzerland
Tillotts Pharma AG 4 Rheinfelden, Switzerland
Numab Therapeutics AG 4 Horgen, Switzerland
NUMAB INNOVATION AG 3 Wädenswil, Switzerland
Numab Innovation AG 3 Waedenswil, Switzerland
NUMAB AG 2 Wadenswil, Switzerland
NUMAB AG 1 Waedenswil, Switzerland
Numab Therapeutics AG 1 Waedenswil, Switzerland
Numab Therapeutics AG 1 Pfaeffikon, Switzerland
Tillotts Pharm AG 1 Rheinfelden, Switzerland

Recent patent applications by MEYER Sebastian

Sebastian MEYER from Eggenwil, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-09-07

US20230279091A1

Chemistry; metallurgy

Anti-TNF-alpha-antibodies and functional fragments thereof

#2 | 2023-08-31

US20230272059A1

Chemistry; metallurgy

Anti-TNF-alpha-antibodies and functional fragments thereof

#3 | 2023-08-03

US20230242651A1

Chemistry; metallurgy

STABLE ANTIBODY VARIABLE DOMAIN FRAMEWORK COMBINATIONS

#4 | 2023-07-06

US20230212265A1

Chemistry; metallurgy

NOVEL ANTIBODY FRAMEWORKS

#5 | 2023-06-22

US20230192897A1

Chemistry; metallurgy

Multispecific antibody comprising CD137 binding domain and PDL1 binding domain

#6 | 2022-12-22

US20220403028A1

Chemistry; metallurgy

NOVEL ANTI-CD3 ANTIBODIES

#7 | 2022-10-20

US20220332797A1

Chemistry; metallurgy

Hetero-dimeric multi-specific antibody format

#8 | 2022-04-28

US20220127350A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, ANTIBODIES TARGETING IL-17A, AND METHODS OF USE THEREOF

#9 | 2021-07-01

US20210198353A1

Chemistry; metallurgy

Anti-TNF-alpha-antibodies and functional fragments thereof

#10 | 2020-10-15

US20200325214A1

Chemistry; metallurgy

Anti-HSA antibodies

#11 | 2020-09-24

US20200299375A1

Chemistry; metallurgy

Anti-TNF-α-antibodies and functional fragments thereof

#12 | 2020-08-13

US20200255533A1

Chemistry; metallurgy

Stable antibody variable domain framework combinations and methods of use thereof

#13 | 2020-06-11

US20200181263A1

Chemistry; metallurgy

Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA

#14 | 2020-04-16

US20200115449A1

Chemistry; metallurgy

Anti-CD3 antibodies

#15 | 2019-06-27

US20190194310A1

Chemistry; metallurgy

Anti-TNF-alpha-antibodies and functional fragments thereof

#16 | 2019-05-23

US20190153089A1

Chemistry; metallurgy

Anti-TNFα-antibodies and functional fragments thereof

#17 | 2019-04-25

US20190119359A1

Chemistry; metallurgy

Antibody frameworks

#18 | 2019-03-28

US20190092850A1

Chemistry; metallurgy

Anti-TNFα-antibodies and functional fragments thereof

#19 | 2018-12-13

US20180355024A1

Chemistry; metallurgy

Hetero-dimeric multi-specific antibody format

#20 | 2018-10-04

US20180282419A1

Chemistry; metallurgy

Bispecific Constructs and Their Use in the Treatment of Various Diseases

#21 | 2017-03-16

US20170073415A1

Chemistry; metallurgy

NOVEL MULTISPECIFIC MOLECULES AND NOVEL TREATMENT METHODS BASED ON SUCH MULTISPECIFIC MOLECULES

#22 | 2016-12-22

US20160368987A1

Chemistry; metallurgy

BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DISEASES

#23 | 2016-05-12

US20160130326A1

Chemistry; metallurgy

Antibody frameworks

#24 | 2016-03-31

US20160090416A1

Chemistry; metallurgy

NOVEL ANTIBODIES

#25 | 2016-03-24

US20160083473A1

Chemistry; metallurgy

CD3 and IL-23 receptor binding bispecific constructs and their use in the treatment of various diseases

InventorID:

1481253 ⎘